Novo CEO Says It Will Take Time to Build Obesity Market
Jan. 30 -- Novo Nordisk A/S Chief Executive Officer Lars Rebien Sorensen says it will take time to build the market for the weight loss treatment Saxenda after winning U.S. regulator approval last month. Novo says 100 million U.S. citizens are classified as obese. Sorensen talks with Jonathan Ferro on Bloomberg Television's "On the Move."
Most Recent Videos
Five Reasons 'Bitcoin Jesus' Loves the Digital Currency
55:26 - One of the earliest investors in the cryptocurrency, Roger Ver, preaches his sometimes controversial gospel of bitcoin. (Source: Bloomberg)